journal article·2026-03

A metal-free cascade nanoreactor reprograms the cystine-glutathione axis for disulfidptosis-pyroptosis therapy

Nan Yang, Changyu Cao, Yunpeng Li, Tian Zhang, Xuejiao Song, Xiaochen Dong, Xiaozhou Mou

Acta Biomaterialia· Volume 213
Publisher page

Abstract

Pyroptosis-based cancer therapy is often hindered by the overexpression of SLC7A11, which enhances glutathione (GSH) biosynthesis to maintain redox homeostasis and suppress pyroptotic cell death. To address this challenge, we developed a metal-free cascade nanoreactor (ITG@PCM) designed to disrupt redox balance via the cystine-GSH axis, thereby enabling synergistic disulfidptosis-pyroptosis therapy. This system employs an organic phase-change material (PCM) to co-encapsulate the photothermal agent IR825, copper chelator TPEN, and glucose oxidase (GOx), with on-demand payload release triggered by the thermal effect under 808 nm laser irradiation. Upon release, GOx catalyzes glucose oxidation, leading to nicotinamide adenine dinucleotide phosphate (NADPH) depletion and consequent actin cytoskeletal collapse, thereby inducing disulfidptosis through abnormal cystine accumulation via SLC7A11. Simultaneously, TPEN chelates Cu2+ from Cu-superoxide dismutase (Cu-SOD), forming Cu2+-TPEN complexes that abolish SOD activity and promote ·O2- accumulation due to impaired dismutation. Notably, Cu2+-TPEN is reduced by GSH to Cu+-TPEN, resulting in GSH depletion and catalyzing H2O2 into highly cytotoxic ·OH via a Fenton-like reaction. The combined effects of GSH depletion and cystine accumulation amplify oxidative stress, thereby activating the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome/caspase-1/gasdermin D (GSDMD) signaling pathway to trigger pyroptosis. Collectively, this cascade-driven dual cell-death mechanism provides a promising paradigm for tumor therapy by precisely disrupting intracellular redox homeostasis. STATEMENT OF SIGNIFICANCE: This work presents a metal-free cascade nanoreactor (ITG@PCM) that strategically disrupts redox homeostasis to induce a synergistic disulfidptosis-pyroptosis anticancer response. By integrating a photothermal agent (IR825), a copper-selective chelator (TPEN), and glucose oxidase within a phase-change matrix, the system enables on-demand, laser-controlled release of therapeutics that simultaneously target the cystine-GSH axis and Cu/Zn-SOD. This dual intervention amplifies oxidative stress through cystine accumulation, GSH depletion, and catalytic hydroxyl radical (·OH) generation, thereby activating the NLRP3 inflammasome to trigger pyroptosis. The approach achieves potent antitumor efficacy without relying on transition-metal nanocatalysts, offering a safer alternative with high translational potential. Notably, this work also provides mechanistic insight into the interplay between disulfidptosis and pyroptosis and establishes a promising paradigm for redox-mediated cancer therapy.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Sulfur Compounds in Biology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (36)

Show source-provided references
1. Melatonin attenuates LPS-induced pyroptosis in acute lung injury by inhibiting NLRP3-GSDMD pathway via activating Nrf2/HO-1 signaling axis10.1016/j.intimp.2022.108782 ↗
2. Fasting-mimicking diet facilitates anti-tumor therapeutic effects by nutrient-sensitive nanocomposites
3. Antineoplastic enzyme as drug carrier with activatable catalytic activity for efficient combined therapy
4. Molecular photoswitching unlocks glucose oxidase for synergistically reinforcing Fenton reactions for antitumor chemodynamic therapy
5. NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications10.1038/s41392-020-00326-0 ↗
6. Switching to the cyclic pentose phosphate pathway powers the oxidative burst in activated neutrophils10.1038/s42255-022-00550-8 ↗
7. The pentose phosphate pathway and cancer10.1016/j.tibs.2014.06.005 ↗
8. The pentose phosphate pathway in health and disease10.1038/s42255-023-00863-2 ↗
9. Energy competition remodels the metabolic glucose landscape of psoriatic epidermal cells10.7150/thno.93764 ↗
10. A noncationic biocatalytic nanobiohybrid platform for cytosolic protein delivery through controlled perturbation of intracellular redox homeostasis10.1002/smll.202407676 ↗
11. Regulation of the pentose phosphate pathway in cancer10.1007/s13238-014-0082-8 ↗
12. Glutaredoxin attenuates glutathione levels via deglutathionylation of Otub1 and subsequent destabilization of system xC−10.1126/sciadv.adi5192 ↗
13. Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11/GSH/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation10.1016/j.redox.2024.103066 ↗
14. Cascade bioreactors based on host–Guest molecular inclusion complexes for triple-negative breast cancer therapy via inducing ferroptosis10.1002/adfm.202309727 ↗
15. Lu · ACS. Nano · 2024 · 18 · 1054210.1021/acsnano.3c12615 ↗
16. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis10.1038/s41556-023-01091-2 ↗
17. Redox-regulating nanotherapeutics potentiating ferroptosis-driven cancer treatment10.1016/j.cej.2024.149518 ↗
18. 2D Indium-vacancy-rich ZnIn2 S4 nanocatalysts for sonocatalytic cancer suppression by boosting cancer-cell pyroptosis
19. A poly-prodrug nanosphere for modulating janus-faced nature of pyroptosis to launch an immune offensive and defensive warfare reigniting the cancer-immunity cycle
20. Situ secondary self-assembly of near-Infrared II J-aggregates: a novel phototheranostic strategy for inducing tumor pyroptosis
21. Engineered nano-micro pyroptosis generators: a magnetic-metallo-immunotherapeutic strategy to reinforce transarterial embolization10.1021/jacs.5c06039 ↗
22. Lysosome-mitochondria cascade targeting nanoparticle drives robust pyroptosis for cancer immunotherapy10.1021/jacs.4c12264 ↗
23. Mitochondria targeting photoredox catalyst-induced pyroptosis for enhanced immunotherapy against hypoxic tumor cells10.1016/j.cej.2024.151599 ↗
24. Modular design and scaffold-synthesis of multi-functional fluorophores for targeted cellular imaging and pyroptosis
25. NIR-II imaging-guided self-enhanced nanomedicine with reactive oxygen species amplification for type I photodynamic therapy of prostate cancer
26. Organic radiosensitizer with aggregation-induced emission characteristics for tumor ablation through synergistic apoptosis and immunogenic cell death10.1021/acsnano.5c00942 ↗
27. Photo-amplified plasma membrane rupture by membrane-anchoring NIR-II small molecule design for improved cancer photoimmunotherapy
28. Photoimmunotherapy-induced pyroptosis remodels the microenvironment to enhance cancer immunotherapy10.1021/acsmaterialslett.4c00581 ↗
29. A highly biocompatible polyoxotungstate with fenton-like reaction activity for potent chemodynamic therapy of tumors10.1002/anie.202422949 ↗
30. Atomically dispersed golds on degradable zero-valent copper nanocubes augment oxygen driven Fenton-like reaction for effective orthotopic tumor therapy10.1038/s41467-022-35515-8 ↗
31. Molecular photoswitching unlocks glucose oxidase for synergistically reinforcing Fenton reactions for antitumor chemodynamic therapy
32. Prussian blue analog with separated active sites to catalyze water driven enhanced catalytic treatments10.1038/s41467-023-40470-z ↗
33. A eutectic mixture of natural fatty acids can serve as the gating material for near-infrared-triggered drug release10.1002/adma.201703702 ↗
34. Phase-change materials based nanoparticles for controlled hypoxia modulation and enhanced phototherapy10.1002/adfm.201906805 ↗
35. Antioxidant enzymes and human diseases10.1016/S0009-9120(99)00075-2 ↗
36. Superoxide dismutase: the first twenty years (1968–1988)10.1016/0891-5849(88)90109-8 ↗